NL-OMON24280尚未招募不适用
Preoperative identification of response to neoadjuvant chemoradiotherapy for esophageal cancer.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 30
研究概览
简要总结
/A
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1. Histologically confirmed carcinoma of the esophagus or esophagogastric junction (i.e. tumors involving both cardia and esophagus on endoscopy);
- •2. Potentially resectable tumor (cT1b-4a N0-3 M0);
排除标准
- •1. Patients who meet exclusion criteria for MRI at 1.5T following the protocol of the Radiology department of the UMC Utrecht;
- •2. Glomerular Filtration Rate (GFR) of <45 mL/min/1.73m2, unless the patient has risk factors for contrast nefropathy according to the UMC Utrecht protocol ‘Preventie contrastreactie en contrast nefropathie, Versie 2 februari 2012’. In patients with risk factors a minimum GFR of 60 mL/min/1.73m2 will be required;
研究者
相似试验
已完成
不适用
Preoperative identification of response to neoadjuvant chemoradiotherapy for esophageal canceresophageal canceroesophageal carcinoma1001799010017991NL-OMON39900niversitair Medisch Centrum Utrecht30
招募中
不适用
Response prediction of neoadjuvant therapy in advanced pancreatic cancer (Neo-Response-Trial)C25Malignant neoplasm of pancreasDRKS00027840Klinik und Poliklinik für Viszeral-, Thorax- und Gefäßchirurgie, Universitätsklinikum Carl Gustav Carus der TU Dresden310
Unknown
不适用
Pre-operative Neoadjuvant Therapy Combined With Surgery for Treating Stage III Hepatocellular CarcinomaHepatocellular Carcinoma Stage IIINCT04961138Second Affiliated Hospital, School of Medicine, Zhejiang University164
已完成
2 期
Open Label Trial for Post-Menopausal Women With Newly Diagnosed Operable Breast CancerBreast CancerNCT00161291University of Alabama at Birmingham28
已完成
不适用
Evaluation of Response to the Neoadjuvant Chemotherapy for Advanced Ovarian Cancer by Multimodal Functional ImagingOvarian CancerNCT02792959Institut Bergonié11